The City of Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing ...
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Editor's note: An earlier version of this story incorrectly stated that a specific type of insulin was excluded from CVS 2017 ...
Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday. The move is aimed at addressing ...
Medicare Part D spending on diabetes drugs increased 364% from 2019 to 2023, driven by GLP-1 and SGLT-2 inhibitors. Metformin spending decreased by 5%, contrasting with the surge in other diabetes ...
WASHINGTON -- Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug ...